Treatment of Patients With Transitional-Cell Carcinoma of the Urothelial Tract With Gemcitabine, Docetaxel and Filgrastim
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Docetaxel (Primary) ; Filgrastim (Primary) ; Gemcitabine (Primary)
- Indications Urogenital cancer
- Focus Therapeutic Use
- 04 Sep 2005 New trial record.